Young-Rock Hong1, Grace L Smith2, Zhigang Xie3, Arch G Mainous3,4, Jinhai Huo3. 1. Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL, USA. youngrock.h@phhp.ufl.edu. 2. Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 3. Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL, USA. 4. Department of Community Health and Family Medicine, University of Florida, Gainesville, FL, USA.
Abstract
PURPOSE: To examine whether the implementation of Affordable Care Act (ACA) reduced the financial burden associated with cancer care among non-elderly cancer survivors. METHODS: Using data from the MEPS-Experiences with Cancer Survivorship Survey, we examined whether there was a difference in financial burden associated with cancer care between 2011 (pre-ACA) and 2016 (post-ACA). Two aspects of financial burden were considered: (1) self-reported financial burden, whether having financial difficulties associated with cancer care and (2) high-burden spending, whether total out-of-pocket (OOP) spending incurred in excess of 10% or 20% of family income. Generalized linear regression models were estimated to adjust the OOP expenditures (reported in 2016 US dollar). RESULTS: Our sample included adults aged 18-64 with a confirmed diagnosis of any cancer in 2011 (n = 655) and in 2016 (n = 490). There was no apparent difference in the prevalence of cancer survivors reporting any financial hardship or being with high-burden spending between 2011 and 2016. The mean OOP decreased by $268 (95% CI, - 384 to - 152) after the ACA. However, we found that the mean premium payments increased by $421 (95% CI, 149 to 692) in the same period. CONCLUSIONS: The ACA was associated with reduced OOP for health services but increased premium contributions, resulting in no significant impact on perceived financial burden among non-elderly cancer survivors. IMPLICATIONS FOR CANCER SURVIVORS: The financial hardship of cancer survivorship points to the need for the development of provisions that help cancer patients reduce both perceived and materialized burden of cancer care under ongoing health reform.
PURPOSE: To examine whether the implementation of Affordable Care Act (ACA) reduced the financial burden associated with cancer care among non-elderly cancer survivors. METHODS: Using data from the MEPS-Experiences with Cancer Survivorship Survey, we examined whether there was a difference in financial burden associated with cancer care between 2011 (pre-ACA) and 2016 (post-ACA). Two aspects of financial burden were considered: (1) self-reported financial burden, whether having financial difficulties associated with cancer care and (2) high-burden spending, whether total out-of-pocket (OOP) spending incurred in excess of 10% or 20% of family income. Generalized linear regression models were estimated to adjust the OOP expenditures (reported in 2016 US dollar). RESULTS: Our sample included adults aged 18-64 with a confirmed diagnosis of any cancer in 2011 (n = 655) and in 2016 (n = 490). There was no apparent difference in the prevalence of cancer survivors reporting any financial hardship or being with high-burden spending between 2011 and 2016. The mean OOP decreased by $268 (95% CI, - 384 to - 152) after the ACA. However, we found that the mean premium payments increased by $421 (95% CI, 149 to 692) in the same period. CONCLUSIONS: The ACA was associated with reduced OOP for health services but increased premium contributions, resulting in no significant impact on perceived financial burden among non-elderly cancer survivors. IMPLICATIONS FOR CANCER SURVIVORS: The financial hardship of cancer survivorship points to the need for the development of provisions that help cancerpatients reduce both perceived and materialized burden of cancer care under ongoing health reform.
Entities:
Keywords:
Affordable Care Act; Financial burden of cancer care; Insurance premiums; Out-of-pocket spending
Authors: Gery P Guy; Donatus U Ekwueme; K Robin Yabroff; Emily C Dowling; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Katherine S Virgo Journal: J Clin Oncol Date: 2013-09-16 Impact factor: 44.544
Authors: Peter J Neumann; Jennifer A Palmer; Eric Nadler; Chihui Fang; Peter Ubel Journal: Health Aff (Millwood) Date: 2010 Jan-Feb Impact factor: 6.301
Authors: Eric A Finkelstein; Florence K Tangka; Justin G Trogdon; Susan A Sabatino; Lisa C Richardson Journal: Am J Manag Care Date: 2009-11 Impact factor: 2.229
Authors: Angela B Mariotto; K Robin Yabroff; Yongwu Shao; Eric J Feuer; Martin L Brown Journal: J Natl Cancer Inst Date: 2011-01-12 Impact factor: 13.506
Authors: K Robin Yabroff; Emily Dowling; Juan Rodriguez; Donatus U Ekwueme; Helen Meissner; Anita Soni; Catherine Lerro; Gordon Willis; Laura P Forsythe; Laurel Borowski; Katherine S Virgo Journal: J Cancer Surviv Date: 2012-07-19 Impact factor: 4.442
Authors: Igor Akushevich; Julia Kravchenko; Lucy Akushevich; Svetlana Ukraintseva; Konstantin Arbeev; Anatoliy I Yashin Journal: Comput Math Methods Med Date: 2011-06-01 Impact factor: 2.238
Authors: Irina B Grafova; Sharon L Manne; Elisa V Bandera; Biren Saraiya; Adana A M Llanos; Katie A Devine; Shawna V Hudson; Lisa E Paddock; Jennifer Tsui; Jennifer Elliott; Antoinette M Stroup; Paul R Duberstein Journal: Support Care Cancer Date: 2021-05-04 Impact factor: 3.603
Authors: Young-Rock Hong; Sandhya Yadav; Ryan Suk; Ahmad Khanijahani; Daniel Erim; Kea Turner Journal: Cancer Med Date: 2021-05-07 Impact factor: 4.452
Authors: Cai Xu; Grace L Smith; Ying-Shiuan Chen; Cristina M Checka; Sharon H Giordano; Kelsey Kaiser; Lisa M Lowenstein; Hilary Ma; Tito R Mendoza; Susan K Peterson; Ya-Chen T Shih; Sanjay Shete; Chad Tang; Robert J Volk; Chris Sidey-Gibbons Journal: PLoS One Date: 2022-08-25 Impact factor: 3.752